
GutSee Health aims to treat chronic gut disorders by engineering the gut microbiome for lasting relief. It operates a SaaS platform powered by a proprietary AI discovery engine that analyzes multi-omics data. The approach combines microbiome engineering, phage technology, and custom CRISPR-like nucleases to design targeted therapies. The PhageX project uses machine learning to predict therapeutic responses and optimize interventions. The goal is scalable precision microbiome therapies for patients worldwide.

GutSee Health aims to treat chronic gut disorders by engineering the gut microbiome for lasting relief. It operates a SaaS platform powered by a proprietary AI discovery engine that analyzes multi-omics data. The approach combines microbiome engineering, phage technology, and custom CRISPR-like nucleases to design targeted therapies. The PhageX project uses machine learning to predict therapeutic responses and optimize interventions. The goal is scalable precision microbiome therapies for patients worldwide.